Thiazolopyridinone derivates as MCH receptor antagonists

Details Thiazolopyridinone derivates as MCH receptor antagonists Thiazolopyridinone derivates as MCH receptor antagonists

2011-03-08

2011-03-08

Chandrakumar, Nizal S (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Chalcogen in the nitrogen containing substituent

C544S128000, C544S362000, C546S114000

Reexamination Certificate

active

07902356

ABSTRACT:
The present invention relates to a melanin concentrating hormone antagonist compound of formula (I); wherein w, R1, q, p, R2, t, Ar1, L1, R3and R4are as defined, or a pharmaceutically acceptable salt, solvate, or enantiomer thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.

REFERENCES:
patent: 1 283 199 (2003-02-01), None
patent: 03/033476 (2003-04-01), None
patent: WO 03/033476 (2003-04-01), None
patent: WO 2004/052848 (2004-06-01), None
patent: 2005/047293 (2005-05-01), None
patent: 2007/093364 (2007-08-01), None
Carpenter, et al., “Melanin-concentrating hormone receptor antagonists as potential antiob,” Expert Opinion on Therapeutic Patents, Ashley Publications, GB, vol. 12, No. 11, pp. 1639-1646 (2002).
Dyck, et al., “A Thienopyridazinone-Based Melanin-Concentrating Hormone Receptor 1 Antagonist with Potent in Vivo Anorectic Properties,” Journal of Medicinal Chemistry, American Chemical Society, vol. 49, No. 13, pp. 3753-3756 (2006).

Affiliated with

Also associated with

Rating

Thiazolopyridinone derivates as MCH receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiazolopyridinone derivates as MCH receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolopyridinone derivates as MCH receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2747533